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Glutamate excitotoxicity leads to fragmented mitochondria in neurodegenerative diseases, mediated by nitric oxide and
S-nitrosylation of dynamin-related protein 1, a mitochondrial outer membrane ﬁssion protein. Optic atrophy gene 1 (OPA1)i sa n
inner membrane protein important for mitochondrial fusion. Autosomal dominant optic atrophy (ADOA), caused by mutations in
OPA1,isaneurodegenerativediseaseaffectingmainlyretinalganglioncells(RGCs).Here,weshowedthatOPA1deﬁciencyinan
ADOA model inﬂuences N-methyl-D-aspartate (NMDA) receptor expression, which is involved in glutamate excitotoxicity and
oxidative stress. Opa1
enu/þ mice show a slow progressive loss of RGCs, activation of astroglia and microglia, and pronounced
mitochondrialﬁssioninopticnerveheadsasfoundbyelectron tomography.ExpressionofNMDA receptors(NR1,2A,and2B)in
the retina of Opa1
enu/þ mice was signiﬁcantly increased as determined by western blot and immunohistochemistry. Superoxide
dismutase 2 (SOD2) expression was signiﬁcantly decreased, the apoptotic pathway was activated as Bax was increased, and
phosphorylated Bad and BcL-xL were decreased. Our results conclusively demonstrate that not only glutamate excitotoxicity
and/or oxidative stress alters mitochondrial ﬁssion/fusion, but that an imbalance in mitochondrial ﬁssion/fusion in turn leads to
NMDA receptor upregulation and oxidative stress. Therefore, we propose a new vicious cycle involved in neurodegeneration
that includes glutamate excitotoxicity, oxidative stress, and mitochondrial dynamics.
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Mutations in optic atrophy type 1 (OPA1), a dynamin-related
GTPase involved in various processes related to mitochon-
drial inner membrane structural dynamics, are linked with
autosomal dominant optic atrophy (ADOA), one of the most
common forms of hereditary optic neuropathy.
1,2 ADOA is
characterized by a moderate to severe decrease in visual
acuity, color vision disturbance, central visual ﬁeld defects,
and temporal optic nerve pallor with juvenile onset.
3,4
The fundamental pathological characteristics based on post
mortem examinations of donor eyes from deceased patients
with ADOA are loss of retinal ganglion cells (RGCs) and
thinning of the nerve ﬁber layer.
3,4 Emerging evidence
suggests that mice carrying heterozygous mutations in the
murine OPA1 gene resemble the human disease phenotype
and thus can be regarded as true models for ADOA.
5–7
Studies on these models provided further evidence for a
causative connection between OPA1 mutations and ascend-
ing RGC death, making ADOA a true neurodegenerative
disease.
8 Nevertheless, the functional role of OPA1 aswell as
the signaling mechanism between OPA1 mutations and RGC
death in ADOA remains unknown. OPA1 has been linked to
different, and in parts disputed, cellular functions, such as
mtDNA stability, maintenance of mitochondrial electron
transport, scavenger of reactive oxygen species, mitochon-
drial coupling, apoptotic signaling, and mitochondrial cristae
remodeling.
9,10 There is only unanimous agreement that
OPA1 is necessary for mitochondrial fusion, because from
yeast, to worm, to ﬂy, to man, all studies describe fragmented
mitochondrial networks upon loss of OPA1 function.
11
Recently, OPA1 has gained more attention from other
ﬁeld of studies, as scientists recognized the importance
of mitochondrial dynamics in many neurodegenerative
diseases, among them the most frequent and most prominent
ones are Alzheimer’s disease, Parkinson’s disease, Hunting-
ton’s disease, and amyotrophic lateral sclerosis.
12–14
Remarkably, glutamate excitotoxicity has been linked to
mitochondrial dysfunction in both acute and chronic neuro-
degenerative disorders.
15–19 In addition, growing evidence
suggests that glutamate excitotoxicity-induced oxidative
stress mediates this mitochondrial dysfunction by disturbing
the closely regulated balance between mitochondrial
ﬁssion and fusion.
20–23 The pro-ﬁssion mitochondrial outer
membrane protein dynamin-related protein 1 (DRP1) is
S-nitrosylated upon high nitric oxide levels produced in
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22Insupportofthis,weshowed
previously that memantine, an uncompetitive N-methyl-D-
aspartate (NMDA) glutamate receptor antagonist, is able to
counteract RGC death in glaucomatous or ischemic retinas,
by preventing OPA1-mediated release of cytochrome c from
the mitochondria.
16,19 Further, increased OPA1 expression
protects RGCs in a mouse model of glaucoma as well as
restores mitochondrial morphology and promotes neuronal
survival following excitotoxicity.
24,25 All of these ﬁndings place
the loss of OPA1 downstream of glutamate excitotoxicity.
Reactive oxygen species including superoxide radicals (O2
 )
induce oxidative stress in many neurodegenerative diseases
including optic neuropathies.
26,27 Superoxide dismutases
(SODs), cytosolic SOD1, and mitochondrial SOD2 are
expressed in the ganglion cell layer (GCL) and inner plexiform
layer(IPL)intherodentretina.
28Emergingevidencesuggests
that SOD2 has a protective role against neuronal cell death
that induced by glutamate excitotoxicity and oxidative
stress.
21 However, the relationship–between OPA1 mutation
and SOD2 in the retina remain unknown.
Here we report that mutations in OPA1 in turn lead to
the upregulation of NMDA glutamate receptors as well as the
downregulation of mitochondrial SOD2 in the retina of
heterozygous Opa1
enu/þ mice. These ﬁndings indicate that
not only glutamate excitotoxicity inﬂuences the mitochondrial
ﬁssion/fusion balance (as suggested before), but also that
altered mitochondrial fusion affects glutamate excitotoxicity.
Therefore, we suggest a new vicious cycle involved in
neurodegeneration that includes glutamate excitotoxicity,
oxidative stress, and mitochondrial dynamics.
Results
Mutant OPA1 induces RGC loss and fragmented
mitochondria in RGC axons. The Opa1
enu/þ mouse strain
carries heterozygously a single-point mutation (c.1065þ
5G-A) in intron 10 of the OPA1 gene that results in an in-
frame deletion of 27 amino-acid residues in the GTPase
domain of the OPA1 protein.
5 Homozygous Opa1
enu/enu mice
are not viable and die during embryogenesis after E8.5.
5
Heterozygous Opa1
enu/þ mice show reduced OPA1 protein
levels in all examined tissues as well as in the retina
(Figures 1a–c).
5 To verify that RGCs indeed express OPA1,
we retrogradely labeled RGCs using FluoroGold and found
that OPA1 protein was present in RGCs in wild-type control
mice (Figures 1d–f). The Opa1
enu/þ mice suffer from a slow
and progressive RGC loss (Supplementary Figure 1 and
Supplementary Table 1),
5,8 which was conﬁrmed by TUNEL-
positive RGCs (Figures 1g and h). RGC loss is accompanied
by activation of both astroglia and microglia as indicated by
signiﬁcantly increased glial ﬁbrillary acidic protein (GFAP)
expression in the retinas of Opa1
enu/þ mice (Figure 2).
3D tomographic reconstructions showed detailed mito-
chondrial membrane structure including the packing arrange-
ment, shape, and density of cristae (Figure 3). Most of the
cristaeinwild-typecontrolmicehavebothtubularandlamellar
compartments. However, some cristae are completely lamel-
lar or completely tubular. In the example shown, both lamellar
and tubular cristae extended transversely (Figures 3a–c).
Mitochondria from Opa1
enu/þ mice appeared shorter
and fragmented (Figures 3d–f). In contrast to the wild-type
mitochondria, a few lamellar cristae are also arranged
longitudinally (Figures 3e and f). There was no difference
in mitochondrial volume density, deﬁned as the volume
occupied by mitochondria divided by the volume occupied
by the axoplasm in terms of a percentage, in the optic nerve
head (ONH) axons (Figure 3g). However, mitochondrial
lengths were signiﬁcantly decreased in the ONH axons of
Opa1
enu/þ micecomparedwithwild-typecontrols(Figure3h).
In contrast, the number of mitochondria, normalized to the
total area occupied by axons in each image, was signiﬁcantly
increased in the ONH axons of Opa1
enu/þ mice compared
with wild-type controls (Figure 3i). Taken together, these
results conclusively show that mutations in the murine OPA1
gene results in increased mitochondrial ﬁssion in ONH axons
of Opa1
enu/þ mice likely contributing to RGC loss. Please see
the Supplementary Movies 1 and 2 for presentations of the
3D tomographic data.
Mutant OPA1 triggers the upregulation of NMDA
receptors. Previous studies reported that increased OPA1
expression restores mitochondrial morphology and promotes
neuronal survival following excitotoxicity, as well as protects
RGCs in a mouse model of glaucoma.
24,25 On the other hand,
it has been shown that glutamate excitotoxicity can alter
mitochondrial dynamics in a process mediated by oxidative
stress.
22 To determine whether impaired mitochondrial
dynamics in the retina of Opa1
enu/þ mice has any inﬂuence
on NMDA receptors, relative changes of NMDA receptor
expression including NR1, NR2A,a n dNR2B were measured
by western blot and immunohistochemistry analyses.
NR1, NR2A, and NR2B protein expressions were
signiﬁcantly increased by 1.75±0.11-, 2.22±0.18-, and
1.48±0.28-fold, respectively, in quantitative western blot
analyses of retinal extracts derived from Opa1
enu/þ mice
compared with wild-type control mice (Figure 4a). These
ﬁndings could be independently conﬁrmed by immunohisto-
chemical analyses. When the primary antibodies were
omitted, as a control for NR1 and NR2A immunohistochem-
istry, there was no labeling by the secondary antibodies in the
retinas of wild-type control mice (Figures 4b and e). NR1
immunoreactivity was present in the GCL of wild-type control
mice (Figure 4c). In Opa1
enu/þ mice, NR1 could be detected
in the GCL as well as in the IPL. NR1 immunoreactivity was
increased in these two cell layers compared with wild-type
controlanimals (Figure4d). Similarly, NR2Aimmunoreactivity
was present in the GCL of wild-type control mice (Figure 4f)
and increased in the inner nuclear layer and GCL of Opa1
enu/
þ mice (Figure 4g). However, for NR2B, antibody showed no
difference. These results demonstrate for the ﬁrst time that
OPA1 mutation triggers the upregulation of NMDA receptors
expression.
Mutant OPA1 decreases antioxidant enzyme SOD2 gene
and protein expressions. As neurodegenerative diseases
have previously been associated with increased oxidative
stress,
18 we examined the expression of antioxidant
enzymes in Opa1
enu/þ mice. In comparison with wild-type
control mice, quantitative PCR analyses showed that
Excitotoxicity and oxidative stress in Opa1
enu/þ mice
D Nguyen et al
2
Cell Death and DiseaseSOD2 mRNA expression was signiﬁcantly decreased by
0.68±0.07-fold in the retinas of Opa1
enu/þ mice (Figure 5a).
To conﬁrm the downregulation of SOD2 protein levels,
SOD2 protein expression was determined in the retinas of
Opa1
enu/þ mice using western blot and immuno-
histochemistry analyses. As shown in Figure 5, quantitative
western blot analyses of retinal extracts revealed that
SOD2 protein expression was signiﬁcantly decreased by
1.75±0.11-fold in the retinas of Opa1
enu/þ mice compared
with wild-type control mice (Figure 5b). This is also in
agreement with the immunohistochemical analysis. When
the primary antibody was omitted, as a control for SOD2
immunohistochemistry, there was no labeling by the
secondary antibody in the retinas of wild-type control mice
(Figure 5c). SOD2 immunoreactivity was present in the outer
plexiform layer (OPL), IPL, and GCL of wild-type control
mice (Figure 5d). However, SOD2 immunoreactivity was
decreased in the OPL, IPL and GCL of Opa1
enu/þ mice
(Figure 5e). These ﬁndings show that mitochondrial depletion
of OPA1 associated with neurodegeneration of the optic
Figure 1 OPA1 mutation reduces OPA1 protein expression and induces apoptotic cell death in the retina of Opa1
enu/þ mice. (a) The OPA1 antibody recognized 90-kDa
(L) and 80-kDa (S) isoforms of OPA1 protein in the total retinal protein extracts of wild-type control and Opa1
enu/þ mice. Opa1
enu/þ mice signiﬁcantly decreased 80-kDa (S)
isoform of OPA1 protein compared with wild-type control mice. Values are mean±S.D. (n¼4 retinas/group). *Signiﬁcant at Po0.05 compared with wild-type control mice.
(bandc)OPA1immunohistochemistry.(b)OPA1immunoreactivitywaspresentintheGCLofwild-typecontrolmouse(arrowheads).Incontrast,OPA1immunoreactivitywas
decreasedintheGCLofOpa1
enu/þ mouse(arrowheads,c).(d–f)OPA1(d)andFluoroGold(e)doublelabeling.NeuronscontainingOPA1immunoractivitywerecolabeledby
FluoroGold (arrowheads), indicating that RGCs contained OPA1 protein. There were no TUNEL-positive cells in the retina of wild-type control mouse (g) while apoptotic cell
deathwasdetectableintheGCLoftheretinaofOpa1
enu/þ mouse(arrow,h).ONL,outernuclearlayer;OPL,outerplexiformlayer;INL,innernuclearlayer;GCL,ganglioncell
layer. Scale bars, 20mm( b–e)
Excitotoxicity and oxidative stress in Opa1
enu/þ mice
D Nguyen et al
3
Cell Death and Diseasenerve involves also oxidative stress in the mouse model
for ADOA.
Mutant OPA1 activates the apoptotic pathway. As
Opa1
enu/þ mice showed an increased number of TUNEL-
positive apoptotic cells in the GCL when compared with wild-
type control mice (Figures 1d and e), known key factors of
the apoptotic cascade were examined for their expression
and/or activity in the retina of Opa1
enu/þ mice and wild-type
control mice. Quantitative PCR analyses demonstrated
signiﬁcantly increased Bax mRNA expression in Opa1
enu/þ
mice compared with wild-type control mice by 1.32±
0.12-fold (Figure 6a). Consistent with this result,
quantitative western blot analysis revealed that Opa1
enu/þ
mice signiﬁcantly increased Bax protein expression by
1.62±0.27-fold in retinal extracts compared with wild-type
control mice (Figure 6b). As the pro-apoptotic Bax/Bak is
counteracted by the anti-apoptotic Bcl-xL, expression levels
of Bcl-xL protein were assessed by western blot analysis.
Intriguingly, Opa1
enu/þ mice signiﬁcantly decreased Bcl-xL
protein expression by 0.46±0.2-fold in the retinal extracts
compared with wild-type control mice (Figure 6b). Further,
Opa1
enu/þ mice signiﬁcantly decreased phosphorylated Bad
(pBad) protein expression by 0.43±0.08-fold in the retinal
extracts compared with wild-type control mice (Figure 6b).
When the primary antibody was omitted, as a control for
Bcl-xL immunohistochemistry, there was no labeling by the
secondary antibody in the retinas of wild-type control mice
(Figure 6c). Bcl-xL immunoreactivity was present in the IPL
and GCL of wild-type control mice (Figure 6d). However,
Figure 2 OPA1 mutation activates both astroglial and microglial cells in Opa1
enu/þ mice. (a) Opa1
enu/þ mice signiﬁcantly increased GFAP expression compared with
wild-type control mice. Values are mean±S.D. (n¼4 retinas/group). *Signiﬁcant at Po0.05 compared with wild-type control mice. (b and c) GFAP immunohistochemistry.
Compared with wild-type control mouse (b), Opa1
enu/þ mouse showed increased GFAP immunoreactivity in the GCL (arrowheads, c). (d–f) Iba1 immunohistochemistry.
(d) Wild-type control mouse showed Iba1-positiveramiﬁed, quiescentmicroglial cell in the IPL (arrowhead). In contrast, Opa1
enu/þ mice showed Iba1-positive microglialcells
that have shortened and thickened processes in the IPL (arrow, e) and GCL (arrow, f). (g and h) GFAP (red), Iba1 (green), and Fluorogold (blue) triple labeling. Note
that FluoroGold-labeled RGC was engulfed by activated microglia cell in the GCL of Opa1
enu/þ mouse (arrow, h). INL, inner nuclear layer; GCL, ganglion cell layer.
Scale bars, 20mm( b–h)
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Cell Death and DiseaseBcl-xL immunoreactivity was decreased in the IPL and GCL
of Opa1
enu/þ mice (Figure 6e). This shows that the apoptotic
pathway is activated in the retina of Opa1
enu/þ mice.
Discussion
ADOA is a true neurodegenerative disease affecting primarily
RGCs.
3,4,8 Mutations in OPA1 account for at least 45% of
all ADOA cases,
29 and the prevalence that a mutation carrier
develops symptoms in his lifetime has been estimated to be
88%.
30 OPA1 is expressed ubiquitously,
1 and previous
studies indicated that RGCs express OPA1 protein in rodent
animals.
16,31 OPA1 mutations or deﬁciency impair mitochon-
drial fusion that results in fragmented mitochondria and
apoptotic cell death in many cell types. More recently, it has
been reported that OPA1 is involved in mitochondrial calcium
homeostasis and mitochondrial dysfunction, suggesting
a possible pathophysiological mechanism in RGC degene-
ration.
25,32,33 Accordingly, recent studies suggest that multi-
systemic neurological features can be found frequently
in patients with OPA1 mutations.
34 The Opa1
enu/þ mouse is
a true model for ADOA
5,8 and intriguingly, it also
displays subclinical neurological and metabolic impairments.
7
Consistent with these results, we found that Opa1
enu/þ mice
had a greater RGC loss than wild-type control mice. Further,
loss of RGCs in Opa1
enu/þ mice is not uniform, which is in
agreement with the human pathology of ADOA. So far, there
isnoconclusiveexplanationfortheseregionaldifferencesand
future studies need to address this in more detail. In addition,
we found that astroglial and microglial cells were remarkably
activated in the GCL of Opa1
enu/þ mice. Although it is
possible thatOpa1mutation-mediated retinal damagemaybe
restricted in the GCL of Opa1
enu/þ mice, the signaling
mechanism between OPA1 mutation and RGC death in the
pathogenesis of ADOA remains unknown.
Glutamate excitotoxicity has been linked to OPA1-related
mitochondrial dysfunction in retinal neurodegeneration
including glaucoma.
16,19 Previously, we demonstrated that
glutamate receptor activation triggers OPA1 release from the
mitochondria in ischemic retinas, and that memantine, an
uncompetitive NMDA glutamate receptor antagonist, blocks
OPA1 and cytochrome c release, and apoptotic cell death in a
mouse model of glaucoma.
16 Therefore, glutamate
excitotoxicity may contribute to OPA1 alteration-mediated
mitochondrial dysfunction and subsequent RGC death in
retinal neurodegeneration. However, it is unknown how OPA1
Figure 3 OPA1 mutation induces mitochondrial ﬁssion in the RGC axons in Opa1
enu/þ mice. OPA1-mutant mitochondria in optic nerve head axons display ﬁssioning.
(a–c) Tomographic reconstruction of a long mitochondrion from an adult wild-type control mouse. (a) A 2.4-nm slice through the center of a tomographic volume of an axon
shows the mitochondrial membrane proﬁles and associations including those of outer and inner boundary membranes and cristae in a long mitochondrion with many cristae.
Scalebar,200nm.(b)Topviewand(c)sideviewofthesegmentedandsurface-renderedvolumeshowingtheoutermembrane(blue)andtheentirecomplementof51cristae
(variouscolors) provide a 3D snapshot of the packingarrangement, shape, anddensity of cristae. Mostof thecristae haveboth tubular and lamellarcompartments. However,
somecristaearecompletelylamellarorcompletelytubular.Bothlamellarandtubularcristaeextendtransversely.(d–f)Tomographicreconstructionofashortermitochondrion
fragmented in two in an optic neve head axon from an adult OPA1-mutant mouse. (d) A 2.4-nm slice through the center of a tomographic volume of an axon shows the
arrangement of outer and inner boundary membranes and cristae. The point of ﬁssion is indicated by the arrow. Note that the two fragmented portions are unequal in size.
Scale bar, 200nm. (e) Top view and (f) side view of the segmented and surface-rendered volume showing the outer membrane (blue) and the nine cristae in the left-hand
fragment and the eight cristae in the right-hand fragment. The left-hand fragment has considerably more lamellar or mixed lamellar/tubular cristae than does the right-hand
fragment. In contrast to the wild-type control mouse mitochondria, a few lamellar cristae are arranged longitudinally in the left fragment. Even though the outer membranes of
thetwofragmentsaretouching,thereisacleanbreak(arrows)betweenfragments.(g)Thereisnodifferenceinmitochondrialvolumedensity,deﬁnedasthevolumeoccupied
bymitochondriadividedbythevolumeoccupiedbytheaxoplasmintermsofapercentage,intheopticnerveheadaxons.Thebaristhemeanandtheerrorbaristhestandard
error of the mean. The number of measurements, corresponding to the number of images measured, is posted at the top of each bar. (h) Mitochondrial lengths are much
shorter in Opa1
enu/þ mouse axons than in the wild-type control mouse axons by a factor of nearly two (*Po0.01). The same images were used as in (g). (i) The number of
mitochondria,normalizedto thetotalareaoccupiedbyaxonsineachimage,ismuchgreaterinOpa1
enu/þ mouseaxonsthaninthewild-typecontrolmouseaxonsbyafactor
greater than two (*Po0.01)
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Cell Death and Diseasemutation induces glutamate excitotoxicity and RGC death. In
the present study, we found that NR1, NR2A, and NR2B
protein expressions were signiﬁcantly increased in the retinas
of Opa1
enu/þ mice, and that immunoreactivities for NR1 and
NR2A were increased mostly in the GCL of Opa1
enu/þ mice.
Further, recent studies by our group as well as other
investigators have shown that increased OPA1 expression
protects RGCs in a mouse model of glaucoma as well as
restores mitochondrial morphology and promotes neuronal
survival following excitotoxicity.
24,25 Together with these
ﬁndings, our results suggest that the mechanism by which
RGC death is induced in Opa1
enu/þ mice involves OPA1
mutation-mediated glutamate excitotoxicity. Future studies
will clarify whether this relationship has an important role
in other neuropathies, since glutamate excitotoxicity has
remarkably been linked to mitochondrial dysfunction in other
neurodegenerative disorders.
15–18,35
We observed that SOD2 gene and protein expression were
signiﬁcantly decreased in the retinas of Opa1
enu/þ mice
compared with wild-type control mice. It has been reported
that overexpression of SOD2 in HT22 mouse hippocampal
neuronal cells reduced the mitochondrial superoxide level,
protected mitochondrial morphology and functions, and
provided resistance against glutamate-induced oxidative
Figure4 OPA1mutationtriggersactivationofNMDAreceptorsinOpa1
enu/þ mice.(a)Opa1
enu/þ micesigniﬁcantlyincreasedNR1,NR2A,andNR2Bproteinexpression
compared with wild-type control mice. Values are mean±S.D. (n¼4 retinas/group). *Signiﬁcant at Po0.05 compared with wild-type control mice. (b–d) NR1
immunohistochemistry. When the primary antibody for NR1 was omitted, there was no binding of the secondary antibody (b). Compared with wild-type control mouse (c),
Opa1
enu/þ mouse showed increased NR1 immunoreactivity in the IPL and GCL (arrowheads, d). (e–g) NR2A immunohistochemistry. When the primary antibody for NR2A
was omitted,there was no binding of the secondary antibody(e). Compared with wild-type control mouse (f), Opa1
enu/þ mouse showedincreased NR2A immunoreactivityin
the GCL (arrowheads, g). ONL, outer nuclear layer; OPL, outer nuclear layer; INL, inner nuclear layer; GCL, ganglion cell layer; NR, NMDA receptor. Scale bar, 20mm( b–g)
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Cell Death and Diseasecytotoxicity, suggesting that SOD2 plays a critical role in
protection against glutamate excitotoxicity-induced oxidative
stress and cell death in neuronal cells.
21 Together with these
ﬁndings, our observations raise the possibility that OPA1
mutation-mediated glutamate excitotoxicity may contribute to
oxidative stress via a reduction of SOD2 expression in the
retina of Opa1
enu/þ mice. Because a recent study suggested
that upregulation of mitochondrial SOD2 by resveratrol
represents an important mechanism for its protection against
cytotoxicity resulting from mitochondrial oxidative stress,
it is possible that the direct enhancement of SOD2 gene
expression in Opa1
enu/þ mice may provide new strategies to
protect against RGC death. We believe that studying the
beneﬁts of blockade of glutamate excitotoxicity or inhibition
of oxidative stress will be rewarding in many optic neuro-
pathies including glaucoma, the most frequent blinding optic
neuropathy in the Western countries.
In the present study, we found that mutant OPA1
signiﬁcantly induces mitochondrial ﬁssion, altering
mitochondrial dynamics. We also found an upregulation of
NMDA receptors and a downregulation of SOD2. Modiﬁca-
tions of this interconnection of glutamate excitotoxicity,
oxidative stress, and mitochondrial morphology seem to be
sufﬁcient to induce the apoptotic pathway, because we found
increased Bax expression as well as decreased Bcl-xL and
phosphorylated Bad levels in the retina of Opa1
enu/þ mice.
Bax is a pro-apoptotic member of the Bcl-2 family that is
essential in many pathways of apoptosis,
36,37 as well as
translocates to discrete foci on the mitochondria during the
initial stages of apoptosis, which subsequently become
mitochondrial scission sites.
38 It is counteracted by Bcl-xL,
which was decreased in its expression in Opa1
enu/þ mice.
Bcl-xL can form heterodimers with dephosphorylated Bad,
which inactivates Bcl-xL and phosphorylation of Bad elim-
inates this dimerization, which activates Bcl-xL. This is in line
with reduced levels of pBad and Bcl-xL, which may contribute
to high Bax levels.
Previously, it has been shown that glutamate excitotoxicity
leads to fragmented mitochondria in neurodegenerative
diseases, mediated by nitric oxide and S-nitrosylation of
Figure 5 OPA1 mutation decreases SOD2 gene and protein expression in Opa1
enu/þ mice. (a) Opa1
enu/þ mice signiﬁcantly decreased SOD2 mRNA expression
compared with wild-type control mice. (b) Opa1
enu/þ mice signiﬁcantly decreased SOD2 protein expression compared with wild-type control mice. Values are mean±S.D.
(n¼4 retinas/group). *Signiﬁcant at Po0.05 compared with wild-type control mice. (c–e) SOD2 immunohistochemistry (green). When the primary antibody for SOD2 was
omitted,therewasnobindingofthesecondaryantibody(c).Comparedwithwild-typecontrolmouse(d),Opa1
enu/þ mouseshoweddecreasedSOD2immunoreactivityinthe
OPL, IPL and GCL (e). ONL, outer nuclear layer; OPL, outer nuclear layer; INL, inner nuclear layer; GCL, ganglion cell layer. Scale bar, 20mm( b–d)
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Cell Death and DiseaseDRP1, a mitochondrial pro-ﬁssion protein. Here we show that
deﬁciency of a mitochondrial pro-fusion protein, OPA1, in turn
upregulates NMDA receptors, which mediate glutamate
excitotoxicity. This involves oxidative stress as a key factor
and leads to the activation of the apoptotic pathway. There-
fore, we suggest a new vicious cycle involved in neurodegen-
erationthatincludesglutamateexcitotoxicity,oxidativestress,
and mitochondrial dynamics. Intervention in this vicious cycle,
by blockade of NMDA receptor activation, enhancement of
SOD2 expression, or inhibition of the downstream apoptotic
cascade may provide new strategies to protect neurons in
neurodegenerative diseases, and in particular RGCs in optic
neuropathies.
Materials and Methods
Animals and genotyping. The B6;C3-Opa1
329–355del mouse line (herein
referred to as Opa1
enu/þ) as a model for ADOA has been described in details
before.
5,7,8 All animals were housed in covered cages, fed with a standard rodent
diet ad libitum, and kept on a 12-h light/12-h dark cycle. All procedures described
wereinaccordancewiththestatementoftheAssociationforResearchinVisionand
Ophthalmology for the use of animals in research.
Tissue preparation. Mice were anesthetized with isoﬂurane and/or
intraperitoneal injection of a mixture of ketamine (100mg/kg, Ketaset; Fort Dodge
Animal Health, Fort Dodge, IA, USA) and xylazine (9mg/kg, TranquiVed; VEDCO
Inc., St. Joseph, MO, USA) before cervical dislocation. For immunohistochemistry,
theretinasweredissectedfromthechoroidsandﬁxedwith4%paraformaldehydein
phosphate buffered saline (PBS, pH 7.4) for 2h at 41C. After several washes
in PBS, the retinas were dehydrated through graded ethanols and embedded in
polyester wax as described previously. For western blot analyses, whole retinas
were immediately used or frozen in liquid nitrogen and stored at  701C until use.
Immunohistochemical analysis. Immunohistochemical staining of 7-mm
wax sections of full thickness retina or whole retina were performed as previously
described.
31 Five sections per wax block from each group (n¼4 retinas/group)
were used for immunohistochemical analysis. Primary antibodies include mouse
monoclonal anti-OPA1 antibody (1:1000; BD Transduction Laboratories, San
Diego,CA,USA),mousemonoclonalanti-GFAPantibody(1:300;Sigma,St.Louis,
MO, USA), rabbit polyclonal anti-Iba1 antibody (1:200; Wako Chemicals USA,
Inc., Richmond, VA, USA), mouse monoclonal anti-NR1 antibody (1:1000; BD
Pharmingen, San Diego, CA, USA), rabbit monoclonal anti-NR2A antibody (1:100;
Millipore, Billerica, MA, USA), rabbit polyclonal anti-SOD2 antibody (1:5000; Santa
Cruz Biotechnology, Inc., Santa Cruz, CA, USA), and rabbit polyclonal anti-Bcl-xL
antibody (1:25; Cell Signaling, Danvers, MA, USA). To prevent non-speciﬁc
background, tissues were incubated in 1% bovine serum albumin/PBS for 1h at
room temperature before incubation with the primary antibodies for 16h at 41C.
Figure 6 OPA1 mutation increases Bax expression, but decreases Bcl-xL and pBad expression in Opa1
enu/þ mice. (a) Opa1
enu/þ mice signiﬁcantly increased Bax
mRNA and protein expression compared with wild-type control mice. (b) Opa1
enu/þ mice signiﬁcantly increased Bax protein expression, but decreased Bcl-xL and pBad
protein expression compared with wild-type control mice. Values are mean±S.D. (n¼4 retinas/group). *Signiﬁcant at Po0.05 compared with wild-type control mice.
(c–e) Bcl-xL immunohistochemistry (green). When the primary antibody for Bcl-xL was omitted, there was no binding of the secondary antibody (c). Compared wild-type
control mouse (d), Opa1
enu/þ mouse showed decreased Bcl-xL immunoreactivity in the IPL and GCL (e). ONL, outer nuclear layer; OPL, outer nuclear layer; INL, inner
nuclear layer; GCL, ganglion cell layer. Scale bar, 20mm( c–e)
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Cell Death and DiseaseAfterseveralwashsteps,thetissueswereincubatedwiththesecondaryantibodies,
Alexa Fluor 488 dye-conjugated goat anti-mouse IgG or Alexa Fluor 568 dye-
conjugated goat anti-rabbit IgG (1:100; Invitrogen, Carlsbad, CA, USA) for 4h at
41C and subsequently washed with PBS. The sections were counterstained with the
nucleic acid stain Hoechst 33342 (1mg/ml, Invitrogen) in PBS. Images were acquired
with confocal microscopy (Olympus FluoView1000; Olympus, Tokyo, Japan).
Western blot analysis. Retinas were dissected from the sclera of wild-type
and Opa1
enu/þ mice. The retinal tissues were then immediately homogenized in a
glass–teﬂon Potter homogenizer in lysis buffer (20mM Hepes, pH 7.5/10mM KCl/
1.5mM MgCl2/1mM EDTA/1mM DTT/0.5% CHAPS/complete protease inhibitors;
Roche Biochemicals, Indianapolis, IN, USA). Ten micrograms of pooled retinal
protein(n¼4retinas/group)fromeachgroupwereseparatedbyPAGEandelectro-
transferred to PVDF membranes. The membrane was blocked with 5% nonfat dry
milk/0.5% Tween-20/PBS for 1h and subsequently incubated with the primary
antibodies overnight. The primary antibodies include mouse monoclonal anti-GFAP
antibody (1:5000; Sigma), mouse monoclonal anti-NR1 antibody (1:1000; BD
Pharmingen), rabbit monoclonal anti-NR2A antibody (1:500; Millipore), mouse
monoclonal anti-NR2B antibody (1:1000; BD Biosciences, San Jose, CA, USA),
rabbit polyclonal anti-SOD-2 antibody (1:5000; Santa Cruz Biotechnology), rabbit
polyclonal anti-Bax antibody (1:500; Santa Cruz Biotechnology), rabbit polyclonal
anti-Bcl-xL antibody (1:1000; Cell Signaling), mouse monoclonal anti-pBad
antibody (1:2000; Cell Signaling), and mouse monoclonal anti-actin antibody
(1:5000; Millipore). After several washes in Tween/PBS, the membranes were
incubated with peroxidase-conjugated goat anti-mouse IgG (1:2000; Bio-Rad,
Hercules, CA, USA) or goat anti-rabbit IgG (1:2000; Bio-Rad) and developed using
chemiluminescence detection (ECL Plus, GE Healthcare Bio-Sciences, Piscataway,
NJ, USA). Images were analyzed by digital ﬂuorescence imager (Storm 860; GE
Healthcare Bio-Sciences) and band densities were normalized using actin as total
extracts calibrator with ImageQuant TL (GE Healthcare Bio-Sciences).
Quantitative PCR. Total RNA from retinal tissues (n¼4 retinas per group)
was extracted with Trizol (Invitrogen), puriﬁed on RNeasy mini columns (Qiagen,
Valencia, CA, USA), and treated with RNase-free DNAse I (Qiagen). The RNA
purity was veriﬁed by conﬁrming that the OD260nm/280nm absorption ratio
exceeded 1.9. The cDNA was synthesized using SuperScript II ﬁrst-strand RT-PCR
kit (Invitrogen). Bax, Bcl2, and SOD2 gene expression were measured by qPCR
(MX3000P, Stratagene, La Jolla, CA, USA) using 25ng of cDNA from retinas and
2  universal PCR master mix (Applied Biosystems, Foster City, CA, USA) with a
one-stepprogram(951Cfor10min,951Cfor30s,and601Cfor1minfor50cycles).
Primers for Bax, Bcl2, SOD2, and GAPDH, as well as Taqman probe for GAPDH
were designed using Primer Express 2.0 software (Supplementary Table 2; Applied
Biosystems), obtained from Biosearch Technologies (Novato, CA, USA). The probe
for Bax, Bcl2, and SOD2 was obtained from the Roche Universal Probe Library
(Roche Diagnostics, Mannheim, Germany), and the optimal concentrations for
probe and primers were determined using heart tissue. Standard curves were
constructed using nine twofold dilutions (50–0.195ng) for both the targets and the
endogenous reference(GAPDH).Thesampleswereruninduplicateforeachtarget
and endogenous GAPDH control.
Electron microscopy. For conventional electron microscopy (EM), two eyes
from each group (n¼2 mice) were ﬁxed via cardiac perfusion with solution at 371C
in 2% paraformaldehyde, 2.5% glutaraldehyde (Ted Pella, Redding, CA, USA) in
0.15M sodium cacodylate (pH 7.4) and placed in pre-cooled ﬁxative on ice for 1h.
The following procedure was used to optimize mitochondrial structural preservation
and membrane contrast.
39 The retinas were dissected with 0.15M sodium
cacodylate plus 3mM calcium chloride (pH 7.4) on ice and then post-ﬁxed with 1%
osmium tetroxide, 0.8% potassium ferrocyanide, 3mM calcium chloride in 0.1M
sodiumcacodylate(pH 7.4)for 1h, washedwith ice-colddistilledwater, poststained
with 2% uranyl acetate at 41C, dehydrated using graded ethanol, and embedded in
Durcupan resin (Fluka, St. Louis, MO, USA). Ultrathin (70nm) sections were
poststained with uranyl acetate and lead salts, and evaluated by a JEOL 1200FX
transmission EM operated at 80kV. Images were recorded on ﬁlm at  8000
magniﬁcation. The negatives were digitized at 1800d.p.i. using a Nikon Cool scan
system, giving an image size of 4033 6010 pixel array and a pixel resolution
of 1.77nm.
39 For quantitative analysis, the number of mitochondria was normalized
to the total area occupied by axons in each image, which was measured
using ImageJ (NIH, Bethesda, MD, USA). Mitochondrial lengths were measured
with ImageJ. The mitochondrial volume density, deﬁned as the volume occupied by
mitochondriadividedbythevolumeoccupiedbytheaxoplasm,wasestimatedusing
stereology as follows. A 112 112 square grid (112 112 chosen for ease of use
with Photoshop) was overlaid on each image loaded in Photoshop (Adobe), and
mitochondria and axoplasm lying under intercepts were counted. The relative
volume of mitochondria was expressed as the ratio of intercepts coinciding with this
organelle relative to the intercepts coinciding with axoplasm.
Electron microscope tomography. Sections of retinas from each group
were cut at thicknesses of 400–500nm. Sections were then stained 30min in 2%
aqueous uranyl acetate, followed by 15min in lead salts. Fiducial cues consisting of
20nm and colloidal gold particles were deposited on opposite sides of the section. For
each reconstruction, a series of images at regular tilt increments was collected with a
JEOL 4000EX intermediate-voltage electron microscope operated at 400kV. The
specimens were irradiated before initiating a tilt series in order to limit anisotropic
specimen thinning during image collection. Tilt series were recorded using a 4k 4k
CCD camera with an angular increment of 21 from  601 to þ601 about an axis
perpendicular to the optical axis of the microscope using a computer-controlled
goniometer to increment accurately the angular steps. The illumination was held to
near parallel beam conditions and optical density maintained constant by varying the
exposure time. The magniﬁcation was  12000and the pixel resolution was 01.2nm.
The IMOD package was used for rough alignment with the ﬁne alignment and
reconstruction performed using the TxBR package.
40 Volume segmentation was
performed by manual tracing in the planes of highest resolution with the program
Xvoxtrace.
40 The mitochondrial reconstructions were visualized using Analyze (Mayo
Foundation, Rochester, MN, USA) or the surface-rendering graphics of Synu (National
Center for Microscopy and Imaging Research, San Diego, CA, USA) as described by
Perkinsetal.
40Theseprogramsallowonetostepthroughslicesofthereconstructionin
any orientation and to track or model features of interest in three dimensions.
Measurements of mitochondrial outer, inner boundary, and cristae membrane surface
areas and volumes were made within segmented volumes by the programs Synuarea
and Synuvolume, respectively (National Center for Microscopy and Imaging
Research). These were used to determine the cristae density, deﬁned as the ratio:
sum of the cristae volumes divided by the mitochondrial volume. Movies of the
tomographic volume were made using Amira.
Retrograde labeling of RGCs. One week before killing, FluoroGold
(1ml/injection of 4% solution; Fluorochrome Inc., Englewood, CO, USA) diluted in
saline was injected bilaterally into the superior colliculi of anesthetized mice with a
mixtureofketamineandxylazineinastereotacticapparatusaspreviouslydescribed.
31
FluoroGold is taken up by the axon terminals of the RGCs and transported
retrogradely to the somas inthe retina. Images of the FluoroGold-labeled RGCs were
captured under an Olympus spinning disk confocal microscope (Olympus America
Inc.,CenterValley,PA,USA)equippedwithahigh-precisionclosedloopXYstageand
closed loop Z control with commercial mosaic acquisition software (MicroBrightField;
MBF Bioscience Inc., Williston, VT, USA). The microscope is equipped with high-
resolution high-sensitive CCD camera for high-speed mosaic acquisition. The
numbers of RGCs in the central, middle, and peripheral retina were counted in a
maskedmannerandaveraged.CarewastakentocountonlyRGCsandnotmicroglia
based on the difference between their morphologies.
TUNEL staining. Sectionswereincubated with proteinaseK (10mg/ml,10mM
Tris, pH 7.4–8.0) for 10min at 371C. After rinsing in PBS, the sections were
incubated with terminal deoxynucleotidyl transferase plus nucleotide mixture in
reaction buffer for 60min at 371C( In situ Cell Death Detection kit, Roche Applied
Science, Indianapolis, IN, USA) as previously described.
Statisticalanalysis. Data were presented as the mean±S.D. Comparison of
two experimental conditions was evaluated using the unpaired Student’s t-test.
Po0.05 was considered to be statistically signiﬁcant.
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